Metastatic Colorectal Cancers Recruiting Phase 3 Trials for Panitumumab (DB01269)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01910610Multi-Line Therapy Trial in Unresectable Metastatic Colorectal CancerTreatment
NCT03231722First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTSTreatment